Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Completed 3Unknown 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Dermatologic 4

Conditions

Keratosis, Actinic 29Carcinoma, Basal Cell 12Melanoma 10Keratosis 4Neoplasm Metastasis 2Skin Neoplasms 1Precancerous Conditions 1Lymphoma, T-Cell, Cutaneous 1Leukoplakia 1Leukokeratosis, Hereditary Mucosal 1Hutchinson's Melanotic Freckle 1Facies 1Carcinoma, Squamous Cell 1

Interventions

Imiquimod 4tirbanibulin 3Cryotherapy 2methyl 5-aminolevulinate 1Tomography, Optical Coherence 1Sugars 1Ointments 1Lasers, Gas 1Fluorouracil 1BF-200 ALA 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Keratosis × Imiquimod × Dermatologic × Clear all
NCT01229319 2011-06-22

Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses

Frankel, Amylynne, M.D.

Phase 4 Unknown
20 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

NCT00116649 2010-07-20

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Graceway Pharmaceuticals, LLC

Phase 4 Completed
551 enrolled 11 charts
Dermatologic

Keratosis, Keratosis, Actinic

NCT00114023 2007-02-19

1-Year Follow up to the 1473-IMIQ Study

Graceway Pharmaceuticals, LLC

Completed
84 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

NCT00115154 2007-02-19

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

Graceway Pharmaceuticals, LLC

Phase 4 Completed
270 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡